Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
1 other identifier
observational
45
1 country
1
Brief Summary
Burning mouth syndrome is an idiopathic condition characterized by symptoms burning and / or pain of the oral mucosa with an orderly clinical finding. So far not found a unique way of treatment. It is a diagnosis that impairs the quality of life of patients, and consequently it can affect the quality of sleep. Melatonin is a hormone secreted from pineal gland and regulates the day-night rhythm of man, and whose production in the body decreases aging. The level of melatonin in saliva correlates well with the level of melatonin in plasma, therefore they are advantages of determining from saliva painlessness and non-invasiveness of the procedure itself. The purpose of this study was to compare the level of melatonin in saliva and the quality of sleep with help of the Epworth Sleepiness Scale in patients with burning mouth syndrome and control groups of patients without subjective oral disorders and with an orderly clinical finding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedMay 25, 2022
May 1, 2022
6 months
March 24, 2022
May 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
determining the level of salivary melatonin
The level of salivary melatonin will be determined in frozen samples of unstimulated saliva samples
January 2021-July 2021
Secondary Outcomes (1)
determining the difference in Epworth's sleepiness scale
January 2021-July 2021
Study Arms (2)
Study group
Female patients of the Department of Oral medicine diagnosed with burning mouth syndrome
Control group
Age-matched female patients without oral lesions and without burning mouth syndrome
Interventions
Unstimulated saliva sample; Epworth's sleepiness scale
Eligibility Criteria
Female patients with burning mouth syndrome and age-matched female controls without burning mouth syndrome or oral lesions will be included in the study. A sample of unstimulated saliva will be taken from all patients and frozen. All patients will also fill in Epworth's sleepiness scale.
You may qualify if:
- female patients
- primary burning mouth syndrome
- without oral lesions
You may not qualify if:
- secondary burning mouth syndrome
- male gender
- patients with oral lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dental Medicine, University of Zagreb
Zagreb, 10000, Croatia
Biospecimen
unstimulated saliva samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor at the Department of Oral Medicine
Study Record Dates
First Submitted
March 24, 2022
First Posted
April 4, 2022
Study Start
January 7, 2021
Primary Completion
July 18, 2021
Study Completion
December 15, 2021
Last Updated
May 25, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share